Lv et al., 2021 - Google Patents
Development of a dual ELISA for the detection of CD2v-unexpressed lower-virulence mutational ASFVLv et al., 2021
View HTML- Document ID
- 17385614285474731536
- Author
- Lv C
- Zhao Y
- Jiang L
- Zhao L
- Wu C
- Hui X
- Hu X
- Shao Z
- Xia X
- Sun X
- Zhang Q
- Jin M
- Publication year
- Publication venue
- Life
External Links
Snippet
African swine fever virus (ASFV) is an important viral pathogen infecting pigs worldwide throughout the pig industry. CD2v (an outer-membrane glycosylated protein of ASFV)- unexpressed lower-virulence mutants have appeared in China and other countries in recent …
- 241000701386 African swine fever virus 0 title abstract description 116
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F3/00—Input arrangements for transferring data to be processed into a form capable of being handled by the computer; Output arrangements for transferring data from processing unit to output unit, e.g. interface arrangements
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yuan et al. | Development of a blocking enzyme-linked immunosorbent assay for detection of antibodies against African swine fever virus | |
Lv et al. | Development of a dual ELISA for the detection of CD2v-unexpressed lower-virulence mutational ASFV | |
Walker et al. | SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays | |
Takheaw et al. | Correlation analysis of anti-SARS-CoV-2 RBD IgG and neutralizing antibody against SARS-CoV-2 Omicron variants after vaccination | |
Lempp et al. | A rapid point-of-care test for the serodiagnosis of hepatitis delta virus infection | |
Faizo et al. | A reliable indirect ELISA protocol for detection of human antibodies directed to SARS-CoV-2 NP protein | |
Tutukina et al. | IgG antibodies develop to spike but not to the nucleocapsid viral protein in many asymptomatic and light COVID-19 cases | |
Wang et al. | Development of an effective double antigen sandwich ELISA based on p30 protein to detect antibodies against African swine fever virus | |
Lee et al. | Comparison of six serological immunoassays for the detection of SARS-CoV-2 neutralizing antibody levels in the vaccinated population | |
Li et al. | Indirect ELISA Using Multi–Antigenic Dominants of p30, p54 and p72 Recombinant Proteins to Detect Antibodies against African Swine Fever Virus in Pigs | |
Ramos et al. | Assessing SARS-CoV-2 neutralizing antibodies after BNT162b2 vaccination and their correlation with SARS-CoV-2 IgG anti-S1, anti-RBD and anti-S2 serological titers | |
Hartlaub et al. | Cross-reaction or co-infection? serological discrimination of antibodies directed against Dugbe and Crimean-Congo hemorrhagic fever orthonairovirus in Nigerian cattle | |
Aubry et al. | Longitudinal analysis and comparison of six serological assays up to eight months post-COVID-19 diagnosis | |
Zarletti et al. | A cell-based ELISA to improve the serological analysis of anti-SARS-CoV-2 IgG | |
Wang et al. | Development of an ELISA method to differentiate animals infected with wild-type African swine fever viruses and attenuated HLJ/18-7GD vaccine candidate | |
Souiri et al. | SARS-CoV-2-neutralizing antibody response and correlation of two serological assays with microneutralization | |
AlKhalifah et al. | Impact of MERS-CoV and SARS-CoV-2 viral infection on immunoglobulin-IgG cross-reactivity | |
Saarinen et al. | Multiplexed high-throughput serological assay for human enteroviruses | |
Zheng et al. | A novel linear B-cell epitope on the P54 protein of African swine fever virus identified using monoclonal antibodies | |
Tajuelo et al. | Cross-recognition of SARS-CoV-2 B-cell epitopes with other Betacoronavirus nucleoproteins | |
Al Saihati et al. | Memory T cells discrepancies in COVID-19 patients | |
Sun et al. | Seroprevalence of Getah virus in pigs in Eastern China determined with a recombinant E2 protein-based indirect ELISA | |
Bhadauria et al. | Antibody response to ChAdOx1 nCoV-19 (AZD1222) vaccine in kidney transplant recipients | |
Cichon et al. | Serological and molecular investigation of Batai virus infections in ruminants from the state of Saxony-Anhalt, Germany, 2018 | |
Cao et al. | Immunogenicity analysis of PCV3 recombinant capsid protein virus-like particles and their application in antibodies detection |